Safety Reporting
Current section refers to the item 4.11 Safety Reporting of the INTEGRATED ADDENDUM TO ICH E6(R1): GUIDELINE FOR GOOD CLINICAL PRACTICE E6(R2). It provides an overview of requirements for reporting of Serious Adverse Events occurring during a clinical trial.
4.11.1 All serious adverse events (SAEs) should be reported immediately to the sponsor except for those SAEs that the protocol or other document (e.g., Investigator's Brochure) identifies as not needing immediate reporting. The immediate reports should be followed promptly by detailed, written reports.
The immediate and follow-up reports should identify subjects by unique code numbers assigned to the trial subjects rather than by the subjects' names, personal identification numbers, and/or addresses.
The investigator should also comply with the applicable regulatory requirement(s) related to the reporting of unexpected serious adverse drug reactions to the regulatory authority(ies) and the IRB/IEC.
4.11.2 Adverse events and/or laboratory abnormalities identified in the protocol as critical to safety evaluations should be reported to the sponsor according to the reporting requirements and within the time periods specified by the sponsor in the protocol.
4.11.3 For reported deaths, the investigator should supply the sponsor and the IRB/IEC with any additional requested information (e.g., autopsy reports and terminal medical reports).
Clinical Research News
Közelgő klinikai vizsgálatok
-
Magnus MedicalCongressionally Directed Medical Research ProgramsToborzás
-
Nicholas ButowskiSiren BiotechnologyMég nincs toborzásGlioma | Agyi neoplazma | Ismétlődő, magas fokú gliomákEgyesült Államok
-
State University of New York at BuffaloMég nincs toborzásBeteg bevonásaEgyesült Államok
-
Poitiers University HospitalMég nincs toborzás
-
Assistance Publique - Hôpitaux de ParisMég nincs toborzásSarlósejtes anaemia | Vaso-okkluzív válság
-
University of California, IrvineToborzásAgyrák | CNS rák | Idegrendszeri rák | Metasztatikus AgydaganatEgyesült Államok
-
Qualia Life SciencesToborzás
-
Guangdong Raynovent Biotech Co., LtdMég nincs toborzás
-
The Hong Kong Polytechnic UniversityWu Jieh Yee Charitable FoundationToborzásFelnőttek | Gyengelátó digitális asszisztens | LátászavarokHong Kong
-
Shanghai General Hospital, Shanghai Jiao Tong University...Még nincs toborzásHasnyálmirigy duktális adenokarcinóma (PDAC)
-
Sun Yat-sen UniversityMég nincs toborzásDohányzás abbahagyása | AI ügynök | Early-Stage Cancer
-
Affiliated Hospital of Nantong UniversityMég nincs toborzás
Clinical Research Jobs
-
Canada - Alberta - CalgaryCanada - Ontario - Kingston
-
United States - Ohio - Cincinnati
-
Ireland - DublinFrance - Ecully
-
United States - North Carolina
-
Serbia - Belgrade
-
India - Bengaluru
-
United States - North Carolina - Morrisville
-
China